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Summary
Microbiome ‘omics approaches can reveal intriguing relationships between the human microbiome and
certain disease states. Along with identification of specific bacteria taxa associated with diseases, recent
scientific advancements provide mounting evidence that metabolism, genetics and environmental factors
can all modulate these microbial effects. However, the current methods for integrating microbiome data
and other covariates are severely lacking. Hence, we present an integrative Bayesian zero-inflated negative
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2 S. Jiang and others
binomial regression model that can both distinguish differentially abundant taxa with distinct phenotypes
and quantify covariate-taxa effects. Our model demonstrates good performance using simulated data. Fur-
thermore, we successfully integrated microbiome taxonomies and metabolomics in two real microbiome
datasets to provide biologically interpretable findings. In all, we proposed a novel integrative Bayesian
regression model that features bacterial differential abundance analysis and microbiome-covariate effects
quantifications, which makes it suitable for general microbiome studies.
Key words: Bayesian regression; Count data; Feature selection; Integrative analysis; Microbiome; Mixture models;
Zero-inflated negative binomial model
1. Introduction
The human microbiome is estimated to contain 3.0×1013 bacteria (Sender and others, 2016) and 3.3×106
microbial genes (Qin and others, 2010). Microbial communities have a profound impact on human health
(Ursell and others, 2012). Recently, microbiome studies have identified disease-associated bacteria taxa
in type 2 diabetes (Karlsson and others, 2013), liver cirrhosis (Qin and others, 2014), inflammatory
bowel disease (Halfvarson and others, 2017), and melanoma patients responsive to cancer immunother-
apy (Frankel and others, 2017). An increasing number of research projects continue to systematically
investigate the role of the microbiome in human diseases (Integrative, 2014).
While innovations in next-generation sequencing technology continue to shape the next steps in the
microbiome field, the statistical methods used in microbiome research have not kept pace. For instance,
metagenomic shotgun sequencing (MSS) generates a massive amount of sequence reads that can provide
species or isolate level taxonomic resolution (Segata and others, 2012). The subsequent comparative
statistical analysis assesses whether specific species are associated with a phenotypic state or experimental
condition.
Upon surveying commonly used statistical approaches, one method focuses on the comparison of
multi-taxa (Chen and others, 2012; Kelly and others, 2015; Zhao and others, 2015; Wu and others,
2016), frequently termed the microbiome community. However, those approaches do not aim to iden-
tify differentially abundant species—making clinical interpretation, mechanistic insights, and biological
validations difficult. Another approach interrogates each individual bacteria taxa for different groups
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or conditions. For example, La Rosa and others (2015) utilizes a Wilcoxon rank-sum test or Kruskal-
Wallis test for groupwise comparisons on microbiome compositional data. Recently, methods developed
for RNA-seq data have been adapted to microbiome studies, e.g. the negative-binomial regression model
in DESeq2 (Love and others, 2014) and overdispersed Poisson model in edgeR (Robinson and others,
2010). These methods, however, are not optimized for microbiome datasets.
Microbial abundance can be affected by covariates, such as metabolites, antibiotics and host genetics.
These confounding variables need to be adjusted for more accurate differential abundance analysis.
Ultimately, there may be a clinical need to quantify the associations between microbiome and clinical
confounders (Kinross and others, 2011; Zhu and others, 2018; Maier and others, 2018). One common
approach is to calculate pairwise correlations between all taxa and covariates (Li and others, 2008),
but this method may be significantly underpowered. Other model-based methods (Chen and Li, 2013;
Wadsworth and others, 2017) have been proposed to detect covariate-taxa associations, but the taxon-
outcome associations have been ignored. Recently, Li and others (2018) developed a multivariate zero-
inflated logistic-normal model to quantify the associations between microbiome abundances and multiple
factors (e.g. disease risk factors or health outcomes) based on microbiome compositional data instead of
the count data.
Here, we propose a Bayesian integrative model to analyze microbiome count data. Our model jointly
identifies differentially abundant taxa among multiple groups and simultaneously quantifies the taxon-
covariate associations. Our modeling construction includes several advantages. First, it characterizes the
over-dispersion and zero-inflation frequently observed in microbiome count data by introducing a zero-
inflated negative binomial (ZINB) model. Second, it models the heterogeneity from different sequencing
depths, covariate effects, and group effects via a log-linear regression framework on the ZINB mean
components. Last, we propose two feature selection processes to simultaneously detect differentially
abundant taxa and estimate the covariate-taxa associations using the spike-and-slab priors. We compute
Bayesian posterior probabilities for these correlated features and provide the Bayesian false discovery rate
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(FDR). Extensive and thorough use of simulated data demonstrates that our model largely improved
performance when compared with existing methods. We present two applications of real microbiome
datasets with various covariate sets. Biological interpretations of our results confirm those of previous
studies and offer a more comprehensive understanding of the underlying mechanism in disease etiology.
The paper is organized as follows. In Section 2, we introduce the integrative hierarchical mixture
model and the prior formulations. Section 3 supplies a brief discussion of the MCMC algorithm and the
resulting posterior inference. In Section 4, we evaluate model performance on simulated data through
a comparison study. We investigate the covariate association in Section 5. Two real data analyses are
shown in Section 6. Our conclusions are presented in Section 7.
2. Hierarchical Model
Our model starts with a high-dimensional count matrix where each entry represents the count of sequence
reads belonging to a taxonomy such as bacterial species. Specifically, we denote Yn×p (usually n  p)
be a microbial abundance matrix, with yij ∈ N, i = 1, . . . , n, j = 1, . . . , p representing the observed
count of the i-th sample and j-th taxon out of the total n samples and p taxa (features). Note that the
proposed model can also be applied to an operational taxonomic unit (OTU) count table obtained via
16S metagenomic approaches. For an OTU table, each feature would be a taxonomic unit of a bacteria
species or genus depending on the sequence similarity threshold (e.g. 97%).We also denote a covariate
matrix Xn×R where each entry xir represents the measurement of the r-th covariate on the i-th sample.
The graphical formulation of the proposed model is summarized in Figure S1 and S2 in the supplement.
2.1 Count generating process
In practice, the microbial abundance matrix Y is characterized by an inflated amount of zeros, resulting
from insufficient sampling depth. Meanwhile, the abundance matrix usually consists of extremely large
counts. Based on these two facts, we assume that each count is sampled from a zero-inflated negative
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binomial (ZINB) distribution so as to simultaneously account for both zero-inflation and over-dispersion
presented in Y :
yij |pi, λij , φj ∼ piI(yij = 0) + (1− pi)NB(yij ;λij , φj), (2.1)
where pi ∈ [0, 1] represents the weight of generating extra zeros, I(·) is an indicator function, and
NB(y;λ, φ) denotes a negative binomial distribution for random variable y with the expectation λ and
dispersion 1/φ. Under this parameterization, the variance of y is λ + λ2/φ. A small value of φ allows
modeling of extra variation. Note that increasing φ towards infinity yields a Poisson distribution with
both expectation and variance equal to λ. We assume a Gamma prior Ga(aφ, bφ) for the dispersion
parameter φ.
An equivalent way to model this count generating process is to introduce a latent binary variable rij ,
such that
yij |rij , λij , φj
{
∼ NB(λij , φj) if rij = 0
= 0 if rij = 1
, (2.2)
where rij is from a Bernoulli distribution with parameter pi, i.e. ∼ Bernoulli(pi). We further impose
pi ∼ Beta(api, bpi), which leads to a Beta-Bernoulli prior for rij with expectation api/(api + bpi).
2.2 Integrative modeling with feature selection
Microbiome count data is characterized by high variability in the number of reads among samples from
different groups (due to distinct biological conditions), or even the same group (due to uneven sequencing
depths). To accommodate this setting, we parameterize the mean parameter λij of the negative binomial
distribution as the multiplicative effects of two positive random effects: 1) the size factor si reflects how the
sequencing depth affects counts across all taxa observed in the i-th sample; 2) the normalized abundance
αij for the j-th taxon in the i-th sample once the sample-specific variability has been accounted for. Our
goal is to find a subset of p taxa that enables us to discriminate the n samples from K distinct groups.
We introduce a binary latent vector γ = (γ1, . . . , γp), with γj = 1 indicating that the j-th taxon has
significantly differential abundances among the K groups, and γj = 0 otherwise. Therefore, conditional
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on rij = 0, we reparameterize the negative binomial kernel of Equation (2.2) as follows:
yij |rij = 0, γj , si, αijk, αij0 ∼
{
NB(yij ; siαij0, φj) if γj = 0
NB(yij ; siαijk, φj) if γj = 1 and zi = k
. (2.3)
Here, zi is the sample allocation indicator. Collectively, zn×1 = (z1, z2, . . . , zn)T indicates the membership
for each sample, where zi = k, k ∈ {1, . . . ,K} reveals that the i-th sample belongs to the k-th group. si
is the size factor of the i-th sample, which can be estimated from the data (see Section 2.3). We assume
an independent Bernoulli prior γj ∼ Bernoulli(ω) for each taxon j, and further impose a beta hyperprior
on ω to formulate a Beta-Bernoulli prior, i.e. ω ∼ Beta(aω, bω). The choice of aω and bω incorporates
the prior belief that a certain percentage of taxa are discriminatory.
We further specify a log-link function to integrate the covariates into the modeling construction for
each normalized abundance:{
logαij0 = µ0j + xiβ
T
j if γj = 0
logαijk = µ0j + µkj + xiβ
T
j if γj = 1 and zi = k
, (2.4)
where µ0j is a feature-specific baseline parameter for taxon j. Note that exp(µ0j)’s can be considered as
scaling factors adjusting for feature-specific levels across all samples. The group-specific parameter µkj
captures the baseline shift between the k-th group and the reference group. We set µkj = 0 if the k-th
group is the reference group to avoid identifiability problems arising from the sum of the components. xi,
the i-th row of covariate matrix X, contains all the covariate measurements for sample i. Here, βj is a 1-
by-R vector, with each element βrj modeling the global effect of the r-th covariate on the observed counts
for the j-th taxon. In practice, not all of the covariates are related to the abundance of a taxon. Therefore,
we allow different sets of covariates to affect different taxa by specifying a spike-and-slab prior (Brown
and others, 1998; Ishwaran and others, 2005) as βrj ∼ (1− δrj)I(βrj = 0) + δrjN(0, σ2βj), where δrj = 1
indicates the r-th covariate is associated with the normalized abundance for the j-th feature, and δrj = 0
otherwise. This modeling approach allows us to identify significant covariate-taxa associations, via the
selection of the nonzero βrj coefficients, for all discriminatory and non-discriminatory taxonomic features.
We complete the model by setting µ0j ∼ N(0, σ20j), µkj ∼ N(0, σ2µj), and δrj ∼ Beta-Bernoulli(ap, bp).
Letting σ20j = 10
2 for all j yields a vague prior for the feature-specific baseline parameter. An inverse-
gamma (IG) hyperprior IG(a, b) is shared by σ2µj and σ
2
βj .
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2.3 Size factor estimation
The parameterization of the negative binomial mean, as shown in Equation (2.3), is a product of the
size factor and the normalized abundance. It is typical to normalize the size factor first to ensure model
identifiability. Hence, the plug-in estimator (equivalent to a point-mass prior) of si is adopted to facilitate
the inference based on the normalized abundance αij as shown in Equation (2.4). The plug-in estimators
can be calculated from the observed count matrix Y . There have been a number of proposals to estimate
the size factors in the context of RNA-seq data analyses. Both Witten (2011) and Li and others (2017)
conducted a comprehensive literature review. However, the assumptions of many existing methods for
RNA-seq are likely not appropriate for highly diverse microbial environments (Weiss and others, 2017).
A so-called cumulative sum scaling (CSS) method has been developed by Paulson and others (2013) as
sˆCSSi ∝
∑p
j=1 yijI(yij 6 q
lCSS
i ), where the default value of lCSS is 50. CSS can be viewed as an adaptive
extension of Bullard and others (2010), and it is better suited for microbiome data. Moreover, a new
normalization method named geometric mean of pairwise ratios (GMPR) has been proposed by Chen
and others (2018), aiming to handle the zero-inflated sequencing data. GMPR calculates the size factor
si based on the median count ratio of nonzero counts between the i-th sample and the remaining samples.
It has been shown to be robust to differential and outlier OTUs. Combining this with some constraints
such as
∑n
i=1 log sˆi = 0 (i.e.
∏n
i=1 sˆi = 1), we are able to obtain a set of identifiable values. In this paper,
both CSS and GMPR are considered.
3. Model Fitting and Posterior Inference
Our model space consists of (R,φ,µ0,M ,B,γ,∆, ω, pi) with the extra zero indicators R = (rij , i =
1, . . . , n, j = 1, . . . , p), the dispersion parameters φ = (φj , j = 1, . . . , p), the feature-specific baselines
µ0 = (µ0j , j = 1, . . . , p), the group-specific baselines M = (µkj , k = 1, . . . ,K, j = 1, . . . , p), the covariate
effects B = (βrj , r = 1, . . . , R, j = 1, . . . , p), the discriminatory taxa indicators γ = (γj , j = 1, . . . , p),
and the association indicators ∆ = (δrj , r = 1, . . . , R, j = 1, . . . , p). We explore the posterior distribution
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via a Markov chain Monte Carlo (MCMC) algorithm based on stochastic search variable selection with
within-model updates (Savitsky and Vannucci, 2010). Full details can be found in the supplement.
We are interested in distinguishing taxa that are differentially abundant among different groups, via γ,
as well as their associations with covariates, via ∆. One way to summarize the posterior distributions of
these binary parameters is via the marginal posterior probability of inclusion (PPI). Suppose t = 1, . . . , T
index the MCMC iterations after burn-in. Then PPI of each γj and δrj can be written as PPI(γj) =
1
T
∑T
t=1 γ
(t)
j and PPI(δrj) =
1
T
∑T
t=1 δ
(t)
rj , respectively. Subsequently, important features and covariates
can be selected based on a given PPI threshold. Following Newton and others (2004), we choose a thresh-
old that controls the Bayesian FDR. Specifically, we solve the following equations to determine the thresh-
olds: FDRγ(cγ) =
∑p
j=1(1−PPI(γj))I(1−PPI(γj)<cγ)∑p
j=1 I(1−PPI(γj)<cγ) , FDR∆(cδ) =
∑R
r=1
∑p
j=1(1−PPI(δrj))I(1−PPI(δrj))<cδ)∑R
r=1
∑p
j=1 I(1−PPI(δrj)<cδ)
,
where I(·) is an indicator function. A well-accepted setting is to set both FDRγ and FDR∆ equal to
0.05, which corresponds to an expected FDR of 5%.
4. Simulation Study
In this section, we evaluated the proposed model using simulated data. In particular, we considered
two methods (CSS and GMPR) introduced in Section 2.3 for estimating the size factor si’s. We also
compared our model with other existing methods described in the prior microbiome studies. In order to
mimic metagenome sequencing data from real data applications (Section 6), we chose the parameters
as follows: we set n samples for K = 2 groups with balanced group size n1 = n2 = n/2. We chose
a large number of candidate features by setting the number of taxa p = 300, and randomly selected
20 true discriminant features to evaluate our model performance. Each row of Y , denoted as yi, was
generated from a Dirichlet-Multinomial distribution as described in Wadsworth and others (2017). For
i = 1, . . . , n, we let yi ∼ Multinomial(Ni, pii) with the row sum Ni ∼ Discrete Uniform(2× 107, 6× 107)
and pii = (pii1, . . . , piip) ∼ Dirichlet(ai). We further incorporated the feature and covariate effects through
ai = (ai1, . . . , aip) by setting aij = exp(a
∗
ij) with a
∗
ij ∼ Normal(µ0j + µkj + xiβTj , σ2e). Here, a larger
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value of σ2e corresponded to a higher noise level. Compared with Equation (2.3), this data generating
process is different from the assumption of the proposed model. We set µ0j ∼ Uniform(8, 10), µ1j = 0
for all j and µ2j = ±2 for all selected discriminating features and 0 otherwise. Then for the covariate
effects, we first obtained the covariate matrix Xn×R by sampling each row xi from the covariate matrix
of the liver cirrhosis study in Section 6.1 (with n = 237 and R = 7). In particular, we sampled n/2
covariate records from healthy and disease groups respectively. For each taxon j, we then randomly
selected m ∈ {0, 2, 4, 6} out of R covariates and let the corresponding βrj ∼ ±Uniform(0.5, 1) while
setting the rest βrj = 0. Lastly, we randomly set pi0np counts in Y to be zeros to mimic the zero-
inflation in the real data. To summarize, we varied the following settings in order to comprehensively
examine the model performance: 1) sample size per group n/2 = 10 or 30; 2) noise level σe = 0.5, 1.0, or
1.5; 3) zero proportion pi0 = 30%, 40%, or 70%. In the main text, we present the results obtained from
the simulated datasets that n/2 = 30, σ2e = 1, and pi0 = 40%, and the remaining results can be found in
Section S2 in the supplement.
The hyperparameters were specified using the following default settings. For the binary variables with
Beta-Bernoulli priors γj ∼ Beta-Bernoulli(aω, bω), δrj ∼ Beta-Bernoulli(ap, bp) and rij ∼ Beta-Bernoulli(api, bpi),
we set aω = 0.2, bω = 1.8, ap = 0.4, and bp = 0.6, which means that 10% of the taxa are expected
to be discriminant features, and 20% of the covariate coefficients to be nonzero. We chose api = bpi = 1
assuming that about half of the zeros are truly missing. For the dispersion parameter with Ga(aφ, bφ)
prior, we set aφ = 1, bφ = 0.01 to obtain a vague gamma prior with mean of 100 and variance of 10,000.
Next, we specified a flat prior IG(a = 2, b = 10) for the variance term σ2µj and σ
2
βj . The sensitivity
analysis reported in the Section S3.2 in the supplement contains more details on the choice of a and
b. When implementing our model on a dataset, we ran four independent chains with different starting
points where each feature or covariate was randomly initialized to have γj = 1 or 0, δrj = 1 or 0. We
set 20, 000 iterations as the default and discarded the first half as burn-in. To assess the concordance
between four chains, we looked at all the pairwise correlation coefficients between the marginal PPI of
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γ and ∆. As mentioned by Stingo and others (2013), high values of correlation suggest that MCMC
chains are run for a satisfactory number of iterations. After ensuring convergence, we assessed our model
performance based on the averaged result over four chains.
Our goal was to identify the discriminating features (e.g. taxa) and the significant feature-covariate
associations (i.e. all nonzero γj and δrj in our model). We thus obtained the PPI for all γj and δrj , and
visualized the accuracy in feature selection using the receiving operating characteristic (ROC) curve.
We also computed the false positive rate when all feature-covariate associations were zero. We further
considered two types of competitors for model comparison. The first type, similar to the proposed model,
can simultaneously identify discriminating features and detect the feature-covariate associations. Here,
we compared with the multivariate zero-inflated logistic-normal (MZILN) regression model proposed by
Li and others (2018). The MZILN model treats the sample allocation vector as an observed covariate
for each sample. Therefore we combined the group label with other observed covariates to create a new
covariate matrix, and the MZILN model gave a regularized estimation of the regression coefficient be-
tween each feature and covariate. The selected discriminating features and feature-covariate associations
corresponded to the nonzero coefficient estimations. The second type of method achieves the same goal
in two separate stages. The first stage consists of four methods to select discriminating features based on
p-values, including the Wilcoxon rank-sum test (Wilcoxon test) and three differential expression analysis
methods implemented by the R packages metagenomeSeq (Paulson and others, 2013), edgeR (Robinson
and others, 2010) and limma (Ritchie and others, 2015). Specifically, metagenomeSeq assumes a zero-
inflated Gaussian model, edgeR models count data using a negative binomial distribution, and limma
adopts a linear model for the log-transformed count data. Then, the discriminating features were selected
to be those with BH (Benjamini and Hochberg, 1995) adjusted p-values smaller than 0.05. To make a
head to head comparison in the first stage, we also included a simplified version of the ZINB model by
excluding the covariate term xiβ
T
j in Equation (2.4). In the second stage, we considered the following fea-
ture selection strategies for each p-value based method. They are: 1) correlation test, 2) lasso regression,
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3) random forest, and 4) multivariate linear regression. We centered the selected discriminating features
by group, and the rest across all samples. For the correlation test, the Pearson correlation coefficients
were calculated between the log scaled compositional data and the covariate measurements for each out-
come group. Next, a Fisher z-transformation (Fisher, 1915) was applied to obtain the p-values for testing
the significance of correlation. For lasso regression, we calculated the true positive rates and the false
positive rates with respect to a range of lasso penalty. For the last two, we fitted a random forest model
or a multivariate linear regression model between each feature and the covariate matrix X, which yielded
variable importance measures or p-values. In all, we have four choices in the first stage {Wilcoxon test,
metagenomeSeq, edgeR, limma} and four choices in the second stage {correlation test, lasso regression,
random forest, multivariate linear regression}, with 4× 4 = 16 choices in total. For clear visualization of
the result, we excluded limma in the second stage due to its relatively inferior performance in the first
stage. We also dropped random forest and linear regression since they showed similar performance as
the lasso regression. Besides, all the p-values generated using different methods were adjusted using the
BH method to control the FDR.
For each of the four scenarios, Figure 1 compares the model performance through the averaged ROC
curve over 100 simulated datasets. We also include the area under curve (AUC) for each approach. For
detecting discriminating features, the proposed method consistently shows high AUC (> 0.98) across all
scenarios, and similar results for capturing the feature-covariate associations (AUC > 0.90). Moreover,
the proposed method maintains a low FDR even when all βrj are 0. The correlation-based method
shows low false positive rates in the case where the true number of contributing covariate is 0, but
has low power when {2, 4, 6} out of 7 covariates have nonzero contribution. In addition, the proposed
model achieves the highest true positive fraction under a fixed small value of FDR in all scenarios,
with the MZILN model and metagenomeSeq performing the second and third best in estimating the
discriminating feature indicator γ (shown in the left column of Figure 1, Figures S3-S5). We also noticed
that the MZILN model could not outperform the two-stage methods in estimating the feature-covariate
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association indicator ∆. The above conclusions hold for using either CSS or GMPR to estimate the
plug-in size factors. To test if our model is robust to the choice of size factor estimation methods, we
further conducted a sensitivity analysis in Section S3.1 in the supplement. The result, as shown in Figure
S6, suggests that our model is considerably robust to the choice of different normalization methods, while
CSS and GMPR have a marginal performance improvement. Furthermore, we reach the same conclusion
with varying group sizes, log-scale noise levels, and zero proportions. In particular, the proposed ZINB
model is robust to a larger amount of extra zeros. Either decreasing the group size or increasing the
noise level hampers the performance of all the methods. Nevertheless, the ZINB model still consistently
outperforms the alternative approaches in estimating γ and ∆. Results are summarized in Figures S3-S5
in the supplement.
5. Feature-Covariate Association Analysis
In this section, we demonstrate that our model can estimate the association between a taxonomic feature
and a covariate by adjusting for the remaining confounders. As a comparison, current approaches rely
on correlation analysis between the pairwise microbiome and covariates. Specifically, those analyses
converted each observed taxonomic count to a fraction (or termed percentages, intensities) by sample.
Next the Pearson correlation coefficients were calculated between the log scaled fractions and the covariate
measurements for each outcome group. Lastly, a Fisher z-transformation (Fisher, 1915) was applied to
obtain the p-values for testing the significance of correlation.
Our model constructs a regression framework to quantify the relationship between the normalized
abundance αijk and covariates through the Equation (2.4). Based on Equation (2.4), given a feature j and
a covariate r of interest, we first normalized the observed abundance using CSS and performed logarithmic
transformation. Next, to calculate xirβˆrj and the group shift µˆkj , we subtracted the estimated feature-
specific influence µˆ0j and other covariates’ impact
∑
r′ 6=r xir′ βˆr′j from the transformed abundance. Lastly,
we could evaluate whether our model provided a reasonable estimation (βˆrj) of the feature-covariate
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association between covariate r and the normalized and adjusted observations of feature j.
Here, we demonstrated the advantages of the proposed model in estimating the feature-covariate
association over the correlation-based method through simulation. For each feature, we randomly selected
four out of seven covariates to have nonzero linear effects on the latent abundances, and generated a
simulated dataset following the description in Section 4. We kept the same prior and algorithm settings
to obtain the estimations for all parameters of interest. We chose a 5% Bayesian FDR for estimating
∆. Among all feature-covariate combinations, the proposed model achieved sensitivity and specificity
rates of 82.9% and 86.7% respectively. We randomly chose several pairs of feature and covariate and
compared the proposed method and the correlation-based method. Figure 2 displays the results of 2
examples, where the true values of δrj were 1. The two dashed lines in Figure 2a or 2b have the same
slope of βˆrj as our estimated covariate effect. Both plots suggest that the proposed model is able to
capture the feature-covariate relationship. Notice that we did not adjust for the group-specific effect.
Hence the differences between two dashed lines represents the group-specific parameter µˆkj . These results
illustrated the advantages in simultaneously detecting the discriminating features and quantifying the
feature-covariate associations. Furthermore, we also validated that the proposed model had correctly
captured the direction of covariate effects in both cases. Figure 2b and 2d show the results from the
correlation-based model. The slope of each dashed line represents the Pearson correlation coefficient.
However, there was no significant result as all p-values were greater than 0.05, suggesting that the
correlation test can be underpowered. The correlation-based method failed to isolate the covariate of
interest from the confounders, and it might suggest a wrong direction of covariate effect, as shown in
Figure 2d.
6. Real data analysis
We applied the proposed model on two real data sets: one with hundreds of samples and the other
with only 24 samples. Compared with the analysis methods used in the original publications, our model
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demonstrates better performance in detecting differentially abundant bacteria. In addition, our model
supports adjusting for biologically meaningful covariates. When adjusting for the metabolic pathway
quantities (or metabolites through metabolomics technology) as covariates, our model estimates the
association between taxa and metabolism-related functions (or metabolites).
6.1 Liver cirrhosis dataset
Cirrhosis is a late-stage condition of scarring or fibrosis of the liver caused by liver disease such as
hepatitis B, hepatitis C, and non-alcoholic fatty liver disease (Abubakar and others, 2015). The liver is
connected to the gastrointestinal tract via the hepatic portal and bile secretion systems. Interestingly,
distinct gut microbiota signatures have been associated with both early-stage liver diseases and end-stage
liver cirrhosis (Garcia-Tsao and Wiest, 2004; Yan and others, 2011; Benten and Wiest, 2012). We applied
our model on a gut microbiome dataset from a liver cirrhosis study carried out by Qin and others (2014).
All metagenome sequenced samples were available from the NCBI Short Read Archive and the curated
microbial abundance matrix was accessible from ExperimentHub (Pasolli and others, 2017).
The full dataset includes 237 samples with their observed microbial abundance matrix Y profiled
from the gut microbiome at the species taxonomic level. The study has two patient groups, including 114
healthy controls and 123 liver cirrhosis patients. We filtered out the taxa with extremely low abundance
before the analysis as suggested in Wadsworth and others (2017). We obtained 528 taxa that had at
least 2 observed counts in both groups for further analysis. As for the covariate information, we used
MetaCyc, a collection of microbial pathways and enzymes involved in metabolism for an extensive amount
of organisms (Caspi and others, 2007). We incorporated the 529 MetaCyc pathway measurements for
237 individuals in the study, and reduced the high correlation among the pathways by average linkage
clustering on their correlation matrix (Wadsworth and others, 2017). Specifically, we kept the pathway
with the largest fold-change between two groups in each cluster, and decided the number of clusters such
that the correlations between the resulting pathways were less than 0.5. Logarithmic transformation and
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normalization (zero mean and unit variance) were applied to the selected covariates to ensure the zero
mean and unit standard deviation. After the pre-processing step, we had seven covariates representing
metabolic functions.
In Qin and others (2014), differential analyses were based on the Wilcoxon test and the p-values were
corrected by the BH method. Although a stringent threshold of significance level (0.0001) was used, the
authors discovered 79 differentially abundant species and had to restrictively report the 30 top candidates
in each group. Figure 5a is the cladogram of the discriminating taxa selected by different methods, with
blue dots representing the results by Qin and others (2014) and red dots reported by the ZINB model.
As suggested in our simulation study, these results may reflect a high FDR as covariate effects were not
factored in the analysis. In addition, the Wilcoxon test cannot account for the pathway effects and thus
the associations between bacteria and metabolic pathways were not identified.
We applied the proposed Bayesian ZINB model to simultaneously analyze the microbial abun-
dance matrix of bacteria and their metabolic pathway abundance. We set a similar hyperparameter
setting as discussed in Section 4 by first specifying aµ = aβ = 2 and bµ = bβ = 10. Next, we set
aω, bω, ap, bp, aφ, bφ to be the same as their default values discussed in Section 4. We ran four inde-
pendent Markov chains with different starting points. Each chain had 40,000 iterations with the first half
discarded as burn-in. We checked the convergence visually and calculated the pairwise Pearson correla-
tion for PPIs, which ranged from 0.988 to 0.994 for γ’s and from 0.982 to 0.989 for δ’s. These concluded
highly consistent results. Figure 4a shows the PPIs for all 528 taxa, where the dashed line represents the
threshold corresponding to an expected FDR of 0.05. We identified 19 differentially expressed taxa, the
majority of which are more abundant in the liver cirrhosis group.
Figure 4c shows the posterior mean of µ2j for all identified discriminating taxa, and Table S1 in
the supplement contains all the detailed parameter estimations for those taxa. Interestingly, two clear
taxonomic branches are distinguished by our model (as indicated by red dots, Figure 5a): the genera
Veillonella and Streptococcus, both of which can originate from the oral cavity. Of note, oral commensal
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bacteria are able to colonize the distal intestinal tract in liver cirrhosis patients (Qin and others, 2014),
probably due to bile acid changes. Veillonella spp. and Streptococcus spp. have been identified as more
abundant in patients with primary biliary cholangitis (Tang and others, 2017), another hepatic disorder
which shares pathophysiologic features with liver cirrhosis (Ridlon and others, 2013). Figure 3a and 3b
show the identified associations between microbiota and metabolic pathways. For example, L-alanine
biosynthesis (PWY0-1061) is positively correlated with Veillonella. Alanine is a gluconeogenesis precur-
sors in liver metabolism, and increased alanine is thought to induce pyruvate kinase in Veillonella. Thus,
this connection between alanine synthesis and Veillonella is intriguing and potentially novel, and biologic
validation experiments might offer further clarification.
6.2 Metastatic melanoma dataset
The proposed Bayesian ZINB model can perform integrative analysis of microbiome taxonomic data
and other omics datasets. In this section, we applied this model to simultaneously analyze microbiome
and metabolomics data from a study of advanced stage melanoma patients receiving immune checkpoint
inhibitor therapy (ICT) (Frankel and others, 2017). The data were collected using MSS and unbiased
shotgun metabolomics. Here, we aim at identifying unique microbiome taxonomic and metabolomic
signatures in those patients who responded favorably to ICT.
A subset of patients in this study (n = 24) were treated with ipilimumab and nivolumab(IN), a
combination therapy that has been shown to be more efficacious than therapy with anti-PD1 or anti-
CTLA4 therapy alone. 16 patients responded to treatment and 8 patients had progression. We performed
quality control steps on MSS reads and profiled them using MetaPhlAn Segata and others (2012) as
described in (Frankel and others, 2017). We filtered out taxa with at most one observation in either
patient group, which left p = 248 taxa from species to kingdom level. For the same fecal samples, we
performed metabolomics profiling and quantified 1,901 patients’ metabolite compounds as the covariate
matrix X. We are interested in statistically assessing how the biochemical volumes between patient
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groups are associated with bacteria burden or quantities. We adopted the same strategy mentioned in
section 6.1 to reduce the correlation between covariates, which resulted in a 24×9 matrix as the covariate
matrix of X.
In the model fitting stage, for prior specification, we used ap = 0.2, bp = 1.8 to obtain a sparser
covariate effect due to the small sample size, and it suggested about 10% of taxa-covariate associations
were significant. We kept the same default setting for the rest of the hyperparameters. Next, we ran four
independent chains with different starting points, and discarded the first half of 40,000 iterations for each
chain. Although the small sample size (n = 24) posed challenges for parameter estimation, the results
showed high pairwise Pearson correlations of PPIs for γ (ranging from 0.989 to 0.992) and δ (ranging
from 0.927 to 0.953). Figure 4b shows the PPIs for all taxa, and Figure 4d illustrates the posterior means
of the selected taxa. Table S2 in the supplement includes detailed parameter estimations of the taxa in
Figure 4d.
Our model jointly identified differentially abundant taxa and revealed the microbiome-metabolite
associations. First, among all seven taxa identified, it is of specific interest to investigate the responder-
enriched taxon Bifidobacterium (genus level), Bifidobacteriaceae (family level). Bifidobacterium, nesting
within Bifidobacteriaceae, is a genus of gram-positive, nonmotile, often branched anaerobic bacteria
(Schell and others, 2002). Bifidobacteria are one of the major genera of bacteria that make up the
gastrointestinal tract microbiota in mammals. This result about Bifidobacterium is supported by recent
melanoma studies. Sivan and others (2015) compared melanoma growth in mice harboring specific micro-
biota, and used sequencing of the 16S ribosomal RNA to identify Bifidobacterium as associated with the
antitumor effects. They also found that oral administration of Bifidobacterium augmented ICT efficacy.
Moreover, Matson and others (2018) detected significant association between several species from Bifi-
dobacterium with patients’ outcomes in an immunotherapy treatment study for metastatic melanoma.
Both studies showed consistent direction of effect, as did our model. The responder-enriched taxon Bifi-
dobacterium were estimated to negatively correlate with 2-oxoarginine and 2-hydroxypalmitate in Figure
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4d. The suppression of these fatty-acid metabolites may induce better cancer treatment as they were
shown to have the oncogenic signaling role in cancer cells (Louie and others, 2013).
7. Conclusion
In this paper, we presented a Bayesian ZINB model for analysis of high-throughput sequencing micro-
biome data. Our method is novel in simultaneously incorporating the effect from measurable genetic
covariates and identifying differentially abundant taxa for multiple patient groups in one statistical
framework. This allows for integrative analysis of microbiome data and other omics data. Our method
is flexible, as it allows for identification and estimation of the association between covariates and each
taxon’s abundance. These results could potentially guide clinical decisions for precision shaping of the
microbiome, although results would need to be validated in preclinical models first. In addition, our
method is computationally efficient in posterior inferences. We implemented the MCMC algorithm to
analyze the data from two MSS studies with results readily available in minutes.
In real data analysis, the identified differentially abundant taxa by our model are often cluttered in
the same phylogenetic branch. These results are achieved without imposing the phylogenetic structures in
the model. This highlights that the results from our model are biologically interpretable and thus capable
of guiding further biological mechanism studies. Our results on the metastatic melanoma study uncover
novel relationships between taxa and metabolites which merit further experimental investigation.
The framework of our model allows for several extensions. For example, the current method supports
two phenotype groups. If there are multiple groups (e.g. the intermediate phenotypes), the current model
can incorporate group-specific parameters while holding the other parameters unchanged (e.g. the nor-
malized microbiome abundance can be inferred in the same way). Then the same posterior inferences can
be applied. The proposed model based on a regression framework considers the microbiome normalized
abundance as the response and integrates the omics data, e.g. metabolite compounds, as predictors. Simi-
larly, Lloyd-Price and others (2019) used the microbial abundance as the response and a type of genomics
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data (i.e. single nucleotide polymorphism, SNP) as predictors to identify several inflammatory bowel dis-
ease (IBD)-associated host-microbial interactions. Both methods focus on the omics effect on microbial
abundance. However, the interaction between the microbiome and the host is bidirectional. Therefore, it
is worthwhile to consider using the microbial features as predictors to investigate their modulations on
any biological process with quantitative omics measurements. For instance, Richards and others (2019)
explored how microbial abundances induced changes in chromatin accessibility and transcription factor
binding of host genetics. Another interesting extension would be to analyze correlated covariates such as
longitudinal clinical measurements (Zhang and others, 2017).
8. Software
An R package IntegrativeBayes is available on GitHub:
https://github.com/shuangj00/IntegrativeBayes.All the simulated datasets and two real datasets
presented in Section 6 are available on figshare:
https://figshare.com/projects/IntegrativeBayesZINB/57980.
9. Supplementary Material
Supplementary material is available online at http://biostatistics.oxfordjournals.org.
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(a) ROC curves for γ (left) and false positive rates for ∆ (right) with all covariate
coefficients βrj as 0
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(b) ROC curves for γ (left) and ∆ (right) with a number of nonzero
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(c) ROC curves for γ (left) and ∆ (right) with a number of nonzero
covariate coefficients βrj of 4
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(d) ROC curves for γ (left) and ∆ (right) with a number of nonzero
covariate coefficients βrj of 6
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Figure 1: Averaged ROC curves for the discriminating feature indicator γ (left) and the feature-covariate
association indicator ∆ (right) with respect to different numbers of nonzero covariate coefficients, i.e.
(a) 0, (b) 2, (c) 4, and (d) 6 out of 7, over 100 replicates in each scenario.
∗The correlation-based methods showed low false positive rates in the case where there is no truly nonzero
covariate coefficients.
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Figure 2: Feature-Covariate Association Analysis: comparison of the results given by the proposed method
((a) and (b)) and correlation-based method((c) and (d)) from the simulated dataset, where the two
features shown (randomly selected for illustration) were truly discriminating with the covariate effect
β1,68 > 0 and β1,127 < 0 by simulation. The proposed method provided a reasonable estimation (βˆrj) of
the feature-covariate association.
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Figure 3: Real Data Analysis: Heatmap showing the effect from covariates, the MetaCyc pathway abun-
dances, in two studies. (a)(b), we use a liver cirrhosis dataset and show the effect between covariate
effects and all microbiome, or differential abundant microbiome, respectively; (c)(d), we use metastatic
melanoma dataset and show the effect between covariate effects and all microbiome, or differential abun-
dant microbiome, respectively;)
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Figure 4: Real Data Analysis: Plots for γ PPI and credible interval. The horizontal dashed line in the
PPI plot represents the threshold controlling the Bayesian false discovery rate < 0.05. All taxa whose
PPI pass the threshold are included in (c) and (d), where each horizontal bar is the 95% credible interval
for µ2j (group-specific parameter) with posterior mean shown in circle. Each arrow in (a), (b) points out
the taxon with largest absolute value of µ2j in one patient group as shown in Figure 4c and 4d.
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Figure 5: Real Data Analysis: Cladograms of the identified discriminating taxa (shown in dots). Red
dots: taxa found by the proposed model; Blue dots: taxa found by methods reported in the original
studies. Each arrow in (a), (b) points out the taxon with the largest absolute value of µ2j (group-specific
parameter) in one patient group, as shown in Figure 4c and 4d.
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Supplementary Material
S1. Details of MCMC Algorithms
First, we write the likelihood function as follows:
K∏
k=1
∏
i:zi=k
∏
j:γj=1,rij=0
Γ(yij + φj)
yij!Γ(φj)
(
φj
sie
µ0j+µkj+xiβTj + φj
)φj (
sie
µ0j+µkj+xiβ
T
j
sie
µ0j+µkj+xiβTj + φj
)yij
×
∏
i
∏
j:γj=0,rij=0
Γ(yij + φj)
yij!Γ(φj)
(
φj
sie
µ0j+xiβTj + φj
)φj (
sie
µ0j+xiβ
T
j
sie
µ0j+xiβTj + φj
)yij
.
Then, we update the parameters in each iteration following the steps below:
1. Update of zero-inflation latent indicator rij : Notice that we only need to update the rij ’s
that correspond to yij = 0. We write the posterior as:
p(rij |yij = 0, φj , zi = k, si, µ0j , µkj , γj)
∝
∫
L(rij |yij = 0, φj , zi = k, µ0j , µkj , γj)× p(rij |pi)× p(pi)dpi
Then it follows that
p(rij |·) ∝

(
φj
sie
µ0j+µkj+xiβ
T
j +φj
)φj(1−rij)
× Be(api+rij ,bpi−rij+1)Be(api,bpi) if γj = 1(
φj
sie
µ0j+xiβ
T
j +φj
)φj(1−rij)
× Be(api+rij ,bpi−rij+1)Be(api,bpi) if γj = 0
2. Update of µ0: We update each µ0j , j = 1, 2, ...p sequentially using an independent Metropolis-
Hasting algorithm. We first propose a new µ∗0j from N(µ0j , τ
2
0 ) and then accept the proposed value
with probability min(1, mMH), where
mMH =
∏n
i=1 f(yij |µ∗0j , µkj , φj , si, γj ,R,X,B)× p(µ∗0j)× J(µ0j ;µ∗0j)∏n
i=1 f(yij |µ0j , µkj , φj , si, γj ,R,X,B)× p(µ0j)× J(µ∗0j ;µ0j)
3. Joint Update of µk· and γ: A between-model step is implemented first to jointly update µk·
and γ. We use an add-delete algorithm, where we select a j ∈ {1, . . . , p} at random and change
the value of γj . For the add case, i.e. γj = 0→ γj = 1, we propose µ∗kj for each k = 2, . . . , n from
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N(0, τ2µj). For the delete case, i.e. γj = 1→ γj = 0, we set µ∗kj = 0 for all k. We finally accept the
proposed values with probability min(1, mMH), where
mMH =
∏n
i=1 f(yij |µ∗kj , µ0j , φj , si, γ∗j ,R,X,B)× p(µ∗kj |γ∗j )× p(γ∗)∏n
i=1 f(yij |µkj , µ0j , φj , si, γj ,R,X,B)× p(µkj |γj)× p(γ)
× J(µkj ;µ
∗
kj |γj ; γ∗j )× J(γ;γ∗)
J(µ∗kj ;µkj |γ∗j ; γj)× J(γ∗;γ)
Further update of µkj when γ
∗
j = 1: A within-model step is followed to further update each
µkj , k = 2, . . . ,K that corresponds to γ
∗
j = 1 in the current iteration. We first propose a new µ
∗
kj
from N(µkj , (τµj/2)
2) and then accept the proposed value with probability min(1,mMH), where
mMH =
∏n
i=1 f(yij |µ∗kj , µ0j , φj , si, γj ,R,X,B)× p(µ∗kj)× J(µkj ;µ∗kj)∏n
i=1 f(yij |µkj , µ0j , φj , si, γj ,R,X,B)× p(µkj)× J(µ∗kj ;µkj)
4. Joint update of β·j and δ·j : Very similar to the above, we perform a between-model step first
using an add-delete algorithm. For each j = 1, . . . , p, we first select an r ∈ {1, . . . , R} at random
and change the value of δrj . For the add case, i.e. δrj = 0→ δrj = 1, we propose β∗rj from N(0, τ2βj).
For the delete case, i.e. δrj = 1 → δrj = 0, we set β∗rj = 0. Then finally we accept the proposed
values with probability min(1,mMH), where
mMH =
∏n
i=1 f(yij |β∗rj , δ∗rj , µ0j , µ·j , si, γj ,R,X)× p(β∗·j |δ∗·j)× p(δ∗·j)∏n
i=1 f(yij |βrj , δrj , µ0j , µ·j , si, γj ,R,X)× p(β·j |δ·j)× p(δ·j)
× J(β·j ;β
∗
·j |δ·j ; δ∗·j)× J(δ·j ; δ∗·j)
J(β∗·j ;β·j |δ∗·j ; δ·j)× J(δ∗·j ; δ·j)
Further update of βrj when δ
∗
rj = 1: A within-model step is followed to further update each
βrj , r = 1, . . . , R that corresponds to δ
∗
rj = 1. We first propose a new β
∗
rj from N(βrj , (σβj/2)
2)
and then accept the proposed value with probability min(1,mMH), where
mMH =
∏n
i=1 f(yij |β∗rj , δrj , µ0j , µ·j , si, φj , γj ,R,X)× p(β∗rj)× J(βrj ;β∗rj)∏n
i=1 f(yij |βrj , δrj , µ0j , µ·j , si, φj , γj ,R,X)× p(βrj)× J(β∗rj ;βrj)
5. Update of φ·: We update each φj j = 1, . . . , p sequentially by using an independent Metropolis-
Hasting algorithm. We first propose a new φ∗j from the normal distribution N(φj , τ
2
φ) that truncated
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at 0, and accept the proposed value with probability min(1,mMH), where
mMH =
∏n
i=1 f(yij |φ∗j , βrj , δrj , µ0j , µ·j , si, γj ,R,X,B)× p(φ∗j )× J(φj ;φ∗j )∏n
i=1 f(yij |φj , βrj , δrj , µ0j , µ·j , si, γj ,R,X,B)× p(φj)× J(φ∗j ;φj)
S2. Results of Simulation Study
We performed a comprehensive simulation study for model comparison. First, we introduce the following
reference setting in the simulation study, that is, 1) n = 60 samples split into K = 2 equally sized groups;
2) p = 300 features, 20 of which were truly discriminating ones; 3) pi0 = 40% false zeros (i.e. structural
zeros) randomly assigned among all counts; 4) R = 7 covariates, four of which true coefficients were
nonzero; 5) noise level 2e = 1. Furthermore, we varied the following settings to comprehensively examine
the model performance, including the choices for sample size per group (n/2 = 10 or 30), the three
log-scale noise levels (σe = 0.5, 1.0, or 1.5) and the extra zero proportions (pi0 = 30%, 40%, or 70%). In
all cases, we randomly set four out of seven nonzero βrj for each taxon j.
S2.1 Evaluation for Sample Size
Figure 8 compares the model performance under two choices of group sizes (n/2 = 10 or 30) with fixed
log-scale noise level at 1.0 and 40% of extra zeros as in the reference setting. Different methods are
compared using the receiving operating characteristic (ROC) curve and area under the curve (AUC).
The left part in Figure 8 shows the results of identifying the differentially abundant taxa (γ) and the
right part is the results of detecting significant covariate-taxa associations (∆). Clearly, decreasing the
sample size hampers the performance of all the methods, but the proposed ZINB model maintains the
highest AUC in both cases, and achieves the highest true positive rate under a fixed small false positive
rate.
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S2.2 Evaluation for Log-scale Noise Level
Figure 9 compares the model performance under three choices of log-scale noise level (σe = 0.5, 1.0,
or 1.5) with fixed group size of n/2 = 30 and 40% extra zeros as in the reference setting. The ZINB
model maintains the highest AUC across all settings of identifying the differentially abundant taxa (AUC
> 0.9), and detecting significant covariate-taxa associations (AUC > 0.8). Notice that the true log-scale
signal level is set to be 2, and the ZINB model still shows an obvious advantage over the alternative
methods under a large log-scale noise level of 1.5.
S2.3 Evaluation for Extra Zero Proportion
Figure S5 compares the model performance under three scenarios of extra zero proportions (pi0 = 30%,
40%, and 70%) with a group size of n/2 = 30 and a noise level of 2e = 1 as in the reference setting.
Although a higher proportion of zeros like 70% dose downgrade the performance of all methods, the
proposed ZINB model is the best under any circumstance. Particularly, our methods always exhibits a
considerably advantage over the others in terms of the identification of feature-covariate association (∆)
as shown in the right column of Figure S5.
S3. Sensitivity Analysis
9.1 Choice of Size Factor Estimation
To assess model robustness with respect to the choice of size factor estimation methods, we compared the
model performance under five typical normalization methods for the analysis of high-dimensional count
data. They are: 1) geometric mean of pairwise ratios (GMPR) proposed by Chen and others (2018); 2)
cumulative sum scaling (CSS) proposed by Paulson and others (2013); 3) The 0.75-th quantile (Q75)
proposed by Bullard and others (2010); 4) trimmed mean of M values (TMM) proposed by Robinson and
Oshlack (2010); 5) relative log expression (RLE) proposed by Anders and Huber (2010). The first two,
designed for normalizing the microbiome count data, have been described in Section 2.3 in the main text,
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while Q75, TMM and RLE are commonly used in RNA-seq data studies. In particular, Q75 calculates
the size factor based on the upper-quantile (75%) of the count distribution of a sample. TMM first sets
a reference sample, and calculates the trimmed mean of the log ratios between all other samples with
the selected reference to estimate size factors. RLE, on the other hand, computes a reference value of
each feature (taxon) as the geometric mean across all samples, and then obtains ratios by dividing all
features by the reference. The size factor for a sample by RLE is set to be the median of the ratios. Due
to the high sparsity observed in the microbiome data, it is needed to add a pseudo-count such as 1 to
the count matrix when using RLE to estimate size factors.
To test if the performance of our model is robust to the choice of different normalization techniques,
we used the simulate datasets generated by the reference setting described in Section 4. The resulting
AUCs for the discriminating feature indicator γ and the feature-covariate association indicator ∆ over
100 data replicates are summarized in Figure S6. First, the result suggests that the proposed ZINB
model is robust with respect to plug-in size factor estimations. Next, the ZINB-CSS and ZINB-GMPR
show better performances due to the smaller variation and slightly higher average AUCs, since both are
based on the normalization methods that better account for the characteristics of the microbiome data.
Notice that RLE is less stable compared to the other methods for such sparse count data, which is also
mentioned in Chen and others (2018).
S3.2 Choice of Inverse-gamma Hyperparameters
We assess impacts of setting priors via sensitivity analysis. In our model, the choice of a and b in the
IG(a, b) prior for σ2µj has an impact on the posterior probabilities of inclusion of γ. To investigate model
performance with respect to the choice of these hyperparameters, we simulated 30 datasets under the
reference setting described in Section 4, and benchmarked our model with varying values of a from 0.5
to 6 and b from 0.5 to 25. The choices of a and b are illustrated in Figure 12.
The results given by different values of (a, b) were compared based on the Matthews correlation
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coefficient (MCC) (Matthews and others, 1985) across 30 replicated datasets. In each replicate, we
controlled a 5% Bayesian false discovery rate and selected discriminating features. We then calculated
the number of true positive (TP), true negative (TN), false positive (FP) and false negative (FN) and
MCC. Here MCC is defined as
MCC =
TP× TN− FP× FN√
(TP + FP)(TP + FN)(TN + FP)(TN + FN)
.
MCC ranges from −1 to 1, and larger values represents favorable prediction results. It is also demon-
strated in the above formula that the MCC-based evaluation is suitable for classes with very different
sizes, since it strikes a balance between TP and FP counts. In our scenario, the size of truly discriminating
features are relatively small compared to the total number. Therefore, we adopt MCC as an appropriate
performance metric to handle the imbalanced setting. As can be seen in Figure 12, given a small value
of b (b 6 2), the MCC is undesirable with any value of a displayed here. As shown by Gelman and others
(2006), the IG(a, b) prior with small a and b would distort the posterior inferences. On the other hand,
if we increase a to have a > 2 while fixing b to be small, the corresponding prior distribution is strongly
informative since IG(a, b) has the mean of b/(a− 2) and the variance of b2/(a− 2)2(a− 1). Therefore, we
choose a = 2 and b = 10 to be the default setting, since this ensures a flat prior and yields a beneficial
variable selection result as shown in Figure 12.
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Figure 6: The graphical formulation of the proposed Bayesian zero-inflated negative binomial regression
model. Node in a circle refers to a parameter of the model. Node in a rectangle is observable data. Circle
nodes in the dashed block are fixed hyperparameters. The link between two nodes represents a direct
probabilistic dependence.
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Parameters:
R = [r·1, . . . , r·j , . . . , r·p]
φ = [φ1, . . . , φj , . . . , φp]
µ0 = [µ01, , . . . , µ0j , . . . , µ0p]
M = [µ·1, . . . ,µ·j , . . . ,µ·p]
B = [β·1, . . . ,β·j , . . . ,β·p]
γ = [γ1, . . . , γj , . . . , γp]
∆ = [δ·1, . . . , δ·j , . . . , δ·p]
Mixture model likelihood:
yij |rij = 0, zi = k, γj = 1 ind∼ NB(yij ; siαijk, φj) with log(αijk) = µ0j + µkj + xTi·β·j
yij |rij = 0, γj = 0 ind∼ NB(yij ; siαij0, φj) with log(αij0) = µ0j + xTi·β·j
yij |rij = 1 ≡ 0
Zero-inflation prior:
rij |pi ∼ Bernoulli(pi), pi ∼ Beta(api , bpi) ⇒ rij |api , bpi ∼ Beta-Bernoulli(rij ; api , bpi)
Feature selection prior:
γj |ω ∼ Bernoulli(ω), ω ∼ Beta(aω , bω) ⇒ γj |aω , bω ∼ Beta-Bernoulli(γj ; aω , bω)
Dispersion prior:
φj ∼ Ga(aφ, bφ)
Feature / Covariate characterization priors:
µ0j |σ0j ∼ N(0, σ20j)
µkj |γj , σkj ∼ (1− γj)I(µkj = 0) + γjN(0, σ2µj) , σ2µj ∼ IG(aµ, bµ)⇒
µkj |γj ∼ (1− γj)I(µkj = 0) + γjt2aµ (0, bµ/aµ)
βrj |δrj , σβj ∼ (1− δrj)I(βrj = 0) + δrjN(0, σ2βj) , σ2βj ∼ IG(aβ , bβ)⇒
βrj |δrj ∼ (1− δrj)I(βrj = 0) + δrjt2aβ (0, bβ/aβ)
Covariate selection prior:
δrj |prj ∼ Bernoulli(prj), prj ∼ Beta(ap, bp) ⇒ δrj |ap, bp ∼ Beta-Bernoulli(δrj ; ap, bp)
Fixed hyperparameters:
σ0j , api , bpi , aω , bω , aφ, bφ, aµ, bµ, aβ , bβ
Posterior:
p(R,φ,µ0,M ,B,γ,∆|Y ,X) ∝
K∏
k=1
∏
i:zi=k
∏
j:γj=1
rij=0
NB(yij ; siαijk, φj)×
∏
i
∏
j:γj=0
rij=0
NB(yij ; siαij0, φj)
×
∏
i,j
Beta-Bernoulli(rij ; api , bpi)×
∏
j
Ga(φj ; aφ, bφ)×
∏
j
N(µ0j ; 0, σ
2
0j)
×
∏
j,k
[(1− γj)I(µkj = 0) + γjt2aµ (µkj ; 0, bµ/aµ)]×
∏
j
Beta-Bernoulli(γj ; aω , bω)
×
∏
r,j
[(1− δrj)I(βrj = 0) + δrjt2aβ (βrj ; 0, bβ/aβ)]×
∏
r,j
Beta-Bernoulli(δrj ; ap, bp)
Figure 7: Hierarchical formulation of the proposed hierarchical mixture model
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(a) ROC curves for γ (left) and ∆ (right) with a sample size per group of n/2 = 30
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(b) ROC curves for γ (left) and ∆ (right) with a sample size per group of n/2 = 10
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Figure 8: Averaged ROC curves for the discriminating feature indicator γ (left) and the feature-covariate
association indicator ∆ (right) with respect to different sample sizes per group (a) n/2 = 30 and (b) 10,
over 100 replicates in each scenario.
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(a) ROC curves for γ (left) and ∆ (right) with a log-scale noise level of σe = 0.5
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(b) ROC curves for γ (left) and ∆ (right) with a log-scale noise level of σe = 1.0
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(c) ROC curves for γ (left) and ∆ (right) with a log-scale noise level of σe = 1.5
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Figure 9: Averaged ROC curves for the discriminating feature indicator γ (left) and the feature-covariate
association indicator ∆ (right) with respect to different noise levels (a) σe = 0.5, (b) σe = 1.0, and (c)
σe = 1.5, over 100 replicates in each scenario.
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(a) ROC curves for γ (left) and ∆ (right) with a false zero proportion of pi0 = 30%
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(b) ROC curves for γ (left) and ∆ (right) with a false zero proportion of pi0 = 40%
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(c) ROC curves for γ (left) and ∆ (right) with a false zero proportion of pi0 = 70%
Methods ZINB−CSSZINB−GMPR
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Figure 10: Averaged ROC curves for the discriminating feature indicator γ (left) and the feature-covariate
association indicator ∆ (right) with respect to different false zero proportions (a) pi0 = 30%, (b) pi0 =
40%, and (c) pi0 = 70%, over 100 replicates in each scenario.
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Liver Cirrhosis Major Parameter Covariate Effect Estimation for Estimation for
Study Estimation by Group Health Liver Cirrhosis
Discriminatory Taxa µ0j µ2j Ave(xβ
T ) Ave(xβT ) Normalized Estimated Normalized Estimated
(ordered by posterior mean of µ2j) (CI for µ0j) (CI for µ2j) Health Liver Cirrhosis log(y·j) α·j log(y·j) α·j
Bacteroides eggerthii 12.93 -0.23 0.47 -0.37 10.79 13.40 8.82 12.32
(12.77, 13.11) (-0.38, -0.08)
Gammaproteobacteria 14.49 0.22 -0.54 0.50 12.52 13.95 14.24 15.22
(14.31, 14.70) (0.07, 0.37)
Veillonella dispar 11.18 0.22 -0.84 0.75 8.14 10.34 10.79 12.16
(10.96, 11.42) (0.06, 0.38)
Bacteroides caccae 13.37 0.23 -0.11 0.12 11.48 13.26 11.88 13.72
(13.19, 13.56) (0.08, 0.38)
Streptococcus salivarius 12.28 0.26 -0.67 0.63 10.22 11.61 12.25 13.17
(12.10, 12.47) (0.11, 0.41)
Haemophilus parainfluenzae 12.98 0.26 -0.57 0.52 10.12 12.40 12.51 13.76
(12.80, 13.18) (0.12, 0.40)
Haemophilus 13.00 0.27 -0.57 0.52 10.13 12.43 12.53 13.79
(12.83, 13.19) (0.12, 0.41)
Streptococcus parasanguinis 11.48 0.28 -0.82 0.76 8.70 10.66 11.38 12.53
(11.29, 11.70) (0.12, 0.42)
Pasteurellales 13.04 0.29 -0.57 0.52 10.14 12.47 12.56 13.84
(12.86, 13.22) (0.13, 0.42)
Pasteurellaceae 13.03 0.29 -0.57 0.52 10.14 12.47 12.56 13.84
(12.86, 13.2) (0.13, 0.43)
Veillonella parvula 12.01 0.29 -0.63 0.63 9.39 11.38 11.96 12.93
(11.83, 12.21) (0.13, 0.43)
Streptococcus 12.88 0.32 -0.66 0.61 10.61 12.22 13.17 13.81
(12.71, 13.05) (0.17, 0.45)
Streptococcaceae 12.89 0.32 -0.66 0.61 10.61 12.22 13.19 13.82
(12.72, 13.07) (0.17, 0.46)
Klebsiella pneumoniae 13.09 0.32 -0.39 0.42 10.38 12.71 11.78 13.84
(12.91, 13.28) (0.17, 0.46)
Bacilli 13.36 0.34 -0.71 0.66 11.03 12.64 13.59 14.36
(13.19, 13.53) (0.19, 0.47)
Klebsiella 13.19 0.34 -0.45 0.48 10.32 12.74 11.69 14.01
(13.00, 13.37) (0.20, 0.48)
Lactobacillales 13.33 0.35 -0.71 0.66 10.88 12.62 13.58 14.34
(13.16, 13.51) (0.20, 0.49)
Veillonella 13.47 0.39 -0.81 0.75 10.27 12.66 13.88 14.61
(13.30, 13.65) (0.25, 0.52)
Veillonella unclassified 12.93 0.40 -0.88 0.83 9.28 12.05 13.27 14.17
(12.75, 13.13) (0.26, 0.55)
Table 1: Liver cirrhosis dataset: parameter estimation for the identified discriminating taxa from the
liver cirrhosis study. Posterior mean and 95% Credible Interval (CI) are reported for the estimated µ0j
(feature-specific baseline parameter) and µ2j(group-specific parameter); Covariate effect represents the
mean of xβˆT of all samples in the corresponding patient group; Normalized log(y·j) is the mean of log
scaled observations after accounting for the sample heterogeneity factor (i.e. size factor) si. Estimated
α·j is the mean of αij for all sample i from the same patient group.
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Liver Cirrhosis Major Parameter Covariate Effect Estimation for Estimation for
Study Estimation by Group Health Liver Cirrhosis
Discriminatory Taxa µ0j µ2j Ave(xβ
T ) Ave(xβT ) Normalized Estimated Normalized Estimated
(ordered by posterior mean of µ2j) (CI for µ0j) (CI for µ2j) Health Liver Cirrhosis log(y·j) α·j log(y·j) α·j
Bifidobacterium 12.50 -1.34 -0.19 0.62 10.78 12.31 10.97 11.79
(12.16, 12.86) (-2.08, -0.62)
Bifidobacteriaceae 12.50 -1.34 -0.19 0.62 10.78 12.31 10.97 11.78
(12.16, 12.86) (-2.07, -0.62)
Bifidobacteriales 12.50 -1.33 -0.19 0.61 10.78 12.31 10.97 11.78
(12.16, 12.86) (-2.06, -0.60)
Clostridium methylpentosum 8.13 0.94 0.18 -0.39 8.21 8.31 8.69 8.68
(5.95, 6.90) (0.54, 1.34)
Carnobacteriaceae 6.40 1.03 0.31 -0.24 6.56 6.71 7.12 7.18
(10.13, 11.22) (0.56, 1.45)
Clostridium bartlettii 10.60 1.40 -0.28 0.46 9.35 10.32 11.19 12.46
(7.88, 8.54) (0.65, 2.15)
Eubacterium siraeum 11.84 1.42 0.30 -0.35 10.70 12.14 12.41 12.92
(11.35, 12.42) (0.64, 2.18)
Table 2: Metastatic melanoma dataset: parameter estimation for the identified discriminating taxa from
the metastatic melanoma study. Posterior mean and 95% Credible Interval (CI) are reported for the
estimated µ0j (feature-specific baseline parameter) and µ2j(group-specific parameter); Covariate effect
represents the mean of xβˆT of all samples in the corresponding patient group; Normalized log(y·j) is the
mean of log scaled observations after accounting for the sample heterogeneity factor (i.e. size factor) si.
Estimated α·j is the mean of αij for all sample i from the same patient group.
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Figure 11: Side-by-side box plots of AUCs for the discriminating feature indicator γ (left) and the
feature-covariate association indicator ∆ (right) with respect to different normalization techniques, over
100 reference simulated datasets. CSS for cumulative sum scaling. GMPR for geometric mean of pairwise
ratios. Q75 for 0.75-th quantile. TMM for trimmed mean of M values. RLE for relative log expression.
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Figure 12: Heatmap of Matthews correlation coefficients (MCC) for the discriminating feature indicator
γ with the choice of (a, b) from the inverse-gamma prior on the variance terms σ2µj and σ
2
βj . Each value
of MCC represents the averaged result of 30 replicates.
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